Clariant Introduces Medical-Grade Master Batches at ICSE

Change may be good under some circumstances, but not when it involves the materials used for medical devices and pharmaceutical packaging. To support industry’s demand for reliability and consistency, materials supplier Clariant has announced that it will unveil its new brand of master batches and compounds for pharmaceutical and medical applications at ICSE 2010, a pharma-focused outsourcing exhibition held from 5 to 7 October at the Villepinte exhibition centre near Paris Charles de Gaulle airport.

The press release issued by Clariant notes that ICSE visitors will be the first to discover how its controlled, compliant and consistent products deliver colour and functionality whilst minimising the risks and costs of noncompliance.

The new brand will be produced at Clariant’s three centres of competence dedicated to the production of specialty formulated master batches and compounds for medical and pharmaceutical applications. The company expects to achieve full ISO 13485:2003 accreditation, having already gained accreditation for two out of the three sites. Located in the United States, Europe and Asia, the plants feature manufacturing-line segregation to reduce risk of cross contamination between products. Consistency and reliability of formulations and procedures is ensured through alignment with the globally harmonised quality management system.

The company will introduce a range of globally harmonised standard colours for PP and PE as well as PEBA materials at the event. The ingredients have been biologically evaluated according to ISO 10993 and USP parts 87 and 88 (Class VI). Clariant’s laser marking and friction-reduction capabilities also will be highlighted at ICSE 2010.

Tags: Clariant, ICSE, medical grade master batch